36 Lanifibranor achieved the primary endpoint with a statistically significant reduction in steatohepatitis evaluated by the steatosis activity fibrosis histological score without worsening fibrosis
Adeva-Andany MM, Calvo-Castro I, Fernandez-Fernandez C, Donapetry-Garcia C, Pedre-Pineiro AM
Due to the novelty of these medications, the research presented at SCAI 2025 Scientific Sessions offers a new perspective for patients and physicians on how GLP-1RAs could improve survival rates for people with or without type 2 diabetes, said SCAI President James B
Night The timing of your supplement can depend on your specific wellness goals
We calculated polygenic scores from genome-wide association studies (GWAS) for 127 traits and diseases, and used these to discover molecular correlates of polygenic risk (e.g., genetic risk for inflammatory bowel disease was negatively correlated with plasma cystine)
The medication works by targeting two key incretin hormone pathways simultaneously